Clinical Trials Browser

Phase 1/2 × Unknown × Urinary Bladder Neoplasms × Clear all

NCT04799847 2023-02-13

Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine

Phase 1/2 Unknown

Urinary Bladder Neoplasms

NCT05108077 2022-01-14

Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells

Phase 1/2 Unknown

Urinary Bladder Neoplasms, Kidney Neoplasms

NCT04922047 2021-06-11

TACBIN-01

Phase 1/2 Unknown

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urogenital Neoplasms, Urologic Neoplasms

NCT03560479 2020-08-19

A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer

Phase 1/2 Unknown

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Neoplasms

NCT02886897 2016-09-01

A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors

Phase 1/2 Unknown

BreastGastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Colorectal Neoplasms

NCT00818350 2009-01-07

Activity Study of Sunitinib In Metastatic Pretreated Urothelial Cancer

Phase 1/2 Unknown

Urinary Bladder Neoplasms